WO/2007/010574 INTEGRATED PRESSURE SENSOR WITH A HIGH FULL-SCALE VALUE||WO||25.01.2007|
||PCT/IT2005/000435||STMICROELECTRONICS S.R.L.||RICOTTI, Giulio|
In an integrated pressure sensor (15) with a high full-scale value, a monolithic body (16) of semiconductor material has a first and a second main surface (16a and 16b), opposite and separated by a substantially uniform distance (w). The monolithic body (16) has a bulk region (17), having a sensitive portion (23) next to the first main surface (16a), upon which pressure (P) acts. A first piezoresistive detection element (18) is integrated in the sensitive portion (23) and has a variable resistance as a function of the pressure (P). The bulk region (17) is a solid and compact region and has a thickness substantially equal to the distance (w).
WO/2006/055561 STEREOISOMERICALLY ENRICHED 3-AMINOCARBONYL BICYCLOHEPTENE PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES||WO||26.05.2006|
||PCT/US2005/041359||RIGEL PHARMACEUTICALS, INC.||ARGADE, Ankush|
The present invention provides stereoisomers and stereoisomeric mixtures of 3-aminocarbonyl-bicycloheptene-2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.
WO/2006/047996 METHOD FOR THE ANALYSIS OF VIBRATIONS GENERATED IN BIOLOGICAL SYSTEMS||WO||11.05.2006|
||PCT/DE2005/001951||KOGANAS, Danielis||KOGANAS, Danielis|
Disclosed is a method for analyzing vibrations generated in biological systems, in which the change of conditions for the probability of a random event to occur compared to the previous cycle can be assessed by introducing an energetic component into the current cycle of the vibration. In order to be able to do so, the analyzed signal is subdivided to the sequence of cycles in such a way that each subsequent cycle is provided with a common interval with the previous adjacent cycle. Such methods are used in the fields of physiology, medicine, and psychology to analyze regulation in biological systems.
WO/2006/049530 LIGHT TOWER, LIGHT TOWER SUPPORT, METHOD FOR OPERATING A LIGHT TOWER AND A LIGHT TOWER CONTROL UNIT FOR CARRYING OUT SAID METHOD||WO||11.05.2006|
||PCT/RU2005/000463||NALITCHAEV, Boris Vladimirovitch||NALITCHAEV, Boris Vladimirovitch|
The invention relates to outdoor lighting devices used mainly in emergency situations. The inventive light tower comprises an inflatable support (4) fixed to a flange (2) which is provided with an air intake opening (3) for pumping compressed air into a shell cavity (7), at least one electric lamp (8) disposed and fixed in the internal cavity (7) of the shell, a foot piece connected to the flange, an air supercharger (10) provided with a motor, a supercharger working cavity (11) connected to the intake opening (3) of the flange and a power supply means connected to the electric lamp and a power supply. A control unit (34) for the light tower and the power transmitting means are mounted on the flange (2). The air supply into the support air cavity (7) is manually and automatically adjustable. The aim of the invention is to extend the functional capabilities of the light tower and to improve the operational reliability thereof.
WO/2006/034004 PROCESSES AND INTERMEDIATES FOR PREPARING CYSTEINE PROTEASE INHIBITORS||WO||30.03.2006|
||PCT/US2005/033051||SCHERING AKTIENGESELLSCHAFT||LI, Jiayao|
The present invention is directed to a process for preparing certain cysteine protease inhibitors.
WO/2006/033700 HER2 ANTIBODY COMPOSITION||WO||30.03.2006|
||PCT/US2005/025084||GENENTECH, INC.||KAO, Yung-Hsiang|
A composition comprising a main species HER2 antibody that binds to domain II of HER2, and an amino acid sequence variant thereof comprising an amino-terminal leader extension is disclosed. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.
WO/2006/030006 SEED DRESSING FORMULATION||WO||23.03.2006|
||PCT/EP2005/054534||CERTIS EUROPE BV||VAN NOOTEN, Kim, Margaretha, Jozef|
The present invention concerns clear water-based microemulsions comprising the antifungal agent flutriafol and their use as a seed dressing.
WO/2006/030739 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINE DERIVATIVES||WO||23.03.2006|
||PCT/JP2005/016761||TAKEDA PHARMACEUTICAL COMPANY LIMITED||URAYAMA, Shinichi|
An industrial process for producing high-purity optically active amine derivatives in high yield while inhibiting the formation of by-products, which comprises subjecting (E)-2- (1, 6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-ylidene)ethylamine to asymmetric reduction, catalytically reducing the obtained product at a reaction temperature of 40 to 100˚C and a pH of 3 to 9, subjecting the obtained (S)-2-(1,6,7,8-tetrahydro -2H-indeno [5,4-b]furan-8-yl)ethylamine to propionylation, and then crystallizing the reaction mixture.
WO/2006/027671 LOW DENSITY POLYURETHANE INTEGRAL SKIN FOAM SYSTEM PREPARED USING EXPANDABLE MICROSPHERES AND WATER AS COBLOWING AGENT||WO||16.03.2006|
||PCT/IB2005/002658||ELACHEM S.R.L.||BRUSA, Federico|
Foamed products with free-rise densities between 0.05 and 0.22 are obtained by reacting at least one polyol with at least one isocyanate-prepolymer, in the presence of an amount of expandable microspheres within the range of 1.0% to 30% by weight on the weight of said polyol and an amount of expanding agent which is from 0.5 to 0.1 times the amount of microspheres, and carrying out the polymer expansion step at a temperature which is sufficient to cause the expansion of the microspheres.
WO/2006/024540 MATERIAL MIXTURE FOR PRODUCING CASTING MOULDS FOR MACHINING METAL||WO||09.03.2006|
||PCT/EP2005/009470||AS LÜNGEN GMBH||WEICKER, Günter|
The invention relates to a material mixture for producing casting moulds for machining metal, to a method for producing casting moulds, and to a method which produces said casting moulds and to the use thereof. A fire-resistant moulding base material and a binding agent based on water glass is used in the production of casting moulds. A proportion of the particle-shaped metal oxide is added to the binding agent, said metal oxide being selected from the group of silicon dioxide, aluminium oxide, titanium oxide and zinc oxide. Synthetic amorphous silicon dioxide is preferably used as a metal oxide.